Severe insulin resistance contrasting with mild anthropometric changes in the adipose tissue of HIV-infected children with lipohypertrophy

International Journal of Obesity

Volumn 27, Issue 1, 2003, Pages 25-30

  Beregszaszi M ^a   Jaquet, D ^a   Levine M ^a   Ortega Rodriguez, E ^a   Baltakse, V ^a   Polak, M ^a   Levy Marchal C ^a  

^a HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

Children; HIV infection; Insulin resistance; Lipodystrophy; Microdialysis

Indexed keywords

GLYCEROL; INSULIN;

ADOLESCENT; ADULT; ANTHROPOMETRY; AREA UNDER THE CURVE; ARTICLE; BODY FAT; CLINICAL ARTICLE; CONTROLLED STUDY; DIALYSATE LEVEL; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ILIAC BONE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPOHYPERTROPHY; MALE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RANK SUM TEST; SKINFOLD THICKNESS; SUBCUTANEOUS FAT;

ADIPOSE TISSUE; BLOOD GLUCOSE; BODY MASS INDEX; CHILD; DIALYSIS; FEMALE; HIV-ASSOCIATED LIPODYSTROPHY SYNDROME; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; SKINFOLD THICKNESS;

HUMAN IMMUNODEFICIENCY VIRUS; RNA VIRUSES;

EID: 0037260652     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0802176     Document Type: Article

References (28)

1. Carr A, Samaras K, Burton S, Law M, Freund J, Chisholm DJ, Cooper DA. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 1998; 12: F51-58.
2. Hadigan C, Meigs JB, Corcoran C, Rietschel P, Piecuch S, Basgoz N, Davis B, Sax P, Stanley T, Wilson PW, D'Agostino RB, Grinspoon S. Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy. Clin Infect Dis 2001; 32: 130-139.
3. Mynarcik DC, McNurlan MA, Steigbigel RT, Fuhrer J, Gelato MC. Association of severe insulin resistance with both loss of limb fat and elevated serum tumor necrosis factor receptor levels in HIV lipodystrophy. J AIDS 2000; 25: 312-321.
4. Paparizos VA, Kyriakis KP, Botsis C, Papastamopoulos V, Hadjivassiliou M, Stavrianeas NG. Protease inhibitor therapy-associated lipodystrophy, hypertriglyceridaemia and diabetes mellitus. [Letter.] AIDS 2000; 14: 903-905.
5. Safrin S, Grunfeld C. Fat distribution and metabolic changes in patients with HIV infection. [Editorial.] AIDS 1999; 13: 2493-2505.
6. Thiebaut R, Daucourt V, Mercie P, Ekouevi DK, Malvy D, Morlat P, Dupon M, Neau D, Farbos S, Marimoutou C, Dabis F. Lipodystrophy, metabolic disorders, and human immunodeficiency virus infection: Aquitaine Cohort, France, 1999. Groupe d'Epidemiologie Clinique du Syndrome d'Immunodeficience Acquise en Aquitaine. Clin Infect Dis 2000; 31: 1482-1487.
7. Vigouroux C, Gharakhanian S, Sahli Y, Nguyen TH, Chevenne D, Capeau J, Rozenbaum W. Diabetes, insulin resistance and dyslipidaemia in lipodystrophic HIV-infected patients on highly active antiretroviral therapy (HAART). Diabet Metab 1999; 25: 225-232.
8. Martinez E, Mocroff A, Garcia-Viejo MA, Pérez-Cuevas JB, Blanco JL, Mallolas J, Bianchi L, Conget I, Blanch J, Phillips A, Gatell JM. Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study. Lancet 2001; 357: 592-598.
9. Goujard C, Boufassa F, Deveau C, Laskri D, Meyer L. Incidence of clinical lipodystrophy in HIV-infected patients treated during primary infection. AIDS 2001; 15: 282-284.
10. Jaquet D, Levine M, Ortega_Rodriguez E, Faye A, Polak M, Vilmer E, Levy-Marchal C. Clinical and metabolic presentation of the lipodystrophic syndrome in HIV-infected children. AIDS 2000; 14: 2123-2128.
11. Arner P, Bolinder J, Eliasson A, Lundin A, Ungerstedt U. Microdialysis of adipose tissue and blood for in vivo lipolysis studies. Am J Physiol 1988; 255: E737-742.
12. Lafontan M, Sengenes C, Galitzky J, Berlan M, De Glisezinski I, Crampes F, Stich V, Langin D, Barbe P, Riviere D. Recent developments on lipolysis regulation in humans and discovery of a new lipolytic pathway. Int J Obes Relat Metab Disord 2000; 24 (Suppl 4): S47-52.
13. Rolland-Cachera MF, Brambilla P, Manzoni P, Akrout M, Sironi S, Del Maschio A, Chiumello G. Body composition assessed on the basis of arm circumference and triceps skinfold thickness: a new index validated in children by magnetic resonance imaging. Am J Clin Nutr 1997; 65: 1709-1713.
14. Rolland-Cachera MF, Sempé M, Guilloud-Bataille M, Patois E, Péquignot-Guggenbuhl F, Fautrad V. Adiposity indices in children. Am J Clin Nutr 1982; 36: 178-184.
15. Rolland-Cachera MF, Cole TJ, Sempé M, Tichet J, Rossignol C, Charraud A. Body Mass Index variations: centiles from birth to 87 years. Eur J Clin Nutr 1991; 45: 13-21.
16. Tanner JM, Whitehouse RH. Clinical longitudinal standards for height, weight, height velocity, weight velocity and stages of puberty. Arch Dis Child 1976; 51: 170-179.
17. Lafontan M, Arner P. Application of in situ microdialysis to measure metabolic and vascular responses in adipose tissue. Trends Pharma Sc 1996; 17: 309-313.
18. Moran A, Jacobs DR, Steinberger J, Hong CP, Prineas R, Luepker R, Sinaiko AR. Insulin resistance during puberty: results from clamp studies in 357 children. Diabetes 1999; 48: 2039-2044.
19. Wentworth JM, Burris TP, Chatterjee VK. HIV protease inhibitors block human preadipocyte differentiation, but not via the PPAR-gamma/RXR heterodimer. J Endocrinol 2000; 164: R7-R10.
20. Zhang B, MacNaul K, Szalkowski D, Li Z, Berger J, Moller DE. Inhibition of adipocyte differentiation by HIV protease inhibitors. J Clin Endocrinol Metab 1999; 84: 4274-4277.
21. Murata H, Hruz PW, Mueckler M. The mechanism of insulin resistance caused by HIV protease inhibitor therapy. J Biol Chem 2000; 275: 20251-20254.
22. Rudich A, Vanounou S, Riesenberg K, Porat M, Tirosh A, Harman-Boehm I, Greenberg AS, Schlaeffer F, Bashan N. The HIV protease inhibitor nelfinavir induces insulin resistance and increases basal lipolysis in 3T3-L1 adipocytes. Diabetes 2001; 50: 1425-1431.
23. Murataa H, Hruza PMM. Indinavir inhibits the glucose transporter isoform Glut4 at physiologic concentrations. AIDS 2002; 16: 859-863.
24. Walli R, Herfort O, Michl GM, Demant T, Jäger H, Dieterle C, Bogner JR, Landgraf R, Goebel FD. Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients. AIDS 1998; 12: F167-173.
25. Noora MA, Seneviratnea T, Aweekac FT, Loa JC, Schwarza JM, Mulligana K, Schambelana MCG. Indinavir acutely inhibits insulin-stimulated glucose disposal in humans: A randomized, placebo-controlled study. AIDS 2002; 16: F1-F8.
26. Keen H, Jarrett RJ, McCartney P. The ten-year follow-up of the Bedford survey (1962-1972): glucose tolerance and diabetes. Diabetologia 1982; 22: 73-78.
27. Bjorntorp P, Sjostrom L. The composition and metabolism in vitro of adipose tissue fat cells of different sizes. Eur J Clin Invest 1972; 2: 78-84.
28. Jacobsson B, Smith U. Effect of cell size on lipolysis and antilipolytic action of insulin in human fat cells. J Lipid Res 1972; 13: 651-656.